Scientific and Medical Equipment House Company (TADAWUL:4014)

TADAWUL:4014 Income Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	922.02	877.23	776.67	713.82	699.45	617.47
Revenue Growth (YoY)	4.78%	12.95%	8.80%	2.05%	13.28%	3.43%
Cost of Revenue	815.23	744.07	647.92	560.04	546.7	467.03
Gross Profit	106.78	133.16	128.75	153.78	152.75	150.45
Selling, General & Admin	64.16	82.9	75.69	78.18	65.89	63.62
Operating Expenses	65.49	78.33	54.18	117.61	70.36	63.62
Operating Income	41.3	54.83	74.56	36.17	82.39	86.83
Interest Expense	-12.95	-25.32	-24.91	-19.65	-12.95	-12.55
Interest & Investment Income	-	-	-	0.05	0.33	0.35
Other Non Operating Income (Expenses)	10.08	16.3	12.5	11.08	14.84	6.69
EBT Excluding Unusual Items	38.43	45.8	62.15	27.65	84.62	81.32
Gain (Loss) on Sale of Assets	0.81	0.09	0.01	0.09	0.22	0.23
Pretax Income	39.39	45.89	62.16	27.74	84.83	81.55
Income Tax Expense	15.96	14.65	15.14	12.12	8.09	7.39
Earnings From Continuing Operations	23.43	31.23	47.02	15.62	76.75	74.16
Earnings From Discontinued Operations	1.37	-6.63	-9.22	-	-	-
Net Income to Company	24.8	24.61	37.8	15.62	76.75	74.16
Minority Interest in Earnings	1.76	1.56	2.26	1.95	0.78	0.6
Net Income	26.56	26.17	40.06	17.57	77.52	74.76
Net Income to Common	26.56	26.17	40.06	17.57	77.52	74.76
Net Income Growth	-35.11%	-34.67%	128.04%	-77.34%	3.70%	5.79%
Shares Outstanding (Basic)	30	30	30	30	30	30
Shares Outstanding (Diluted)	30	30	30	30	30	30
EPS (Basic)	0.89	0.87	1.34	0.59	2.58	2.49
EPS (Diluted)	0.89	0.87	1.34	0.59	2.58	2.49
EPS Growth	-34.84%	-34.67%	128.04%	-77.34%	3.70%	5.79%
Free Cash Flow	34.84	281.35	-155.51	133.46	-79.49	94.34
Free Cash Flow Per Share	1.17	9.38	-5.18	4.45	-2.65	3.15
Dividend Per Share	-	1.000	1.000	-	0.667	1.000
Dividend Growth	-	-	-	-	-33.33%	-
Gross Margin	11.58%	15.18%	16.58%	21.54%	21.84%	24.37%
Operating Margin	4.48%	6.25%	9.60%	5.07%	11.78%	14.06%
Profit Margin	2.88%	2.98%	5.16%	2.46%	11.08%	12.11%
Free Cash Flow Margin	3.78%	32.07%	-20.02%	18.70%	-11.36%	15.28%
EBITDA	51.65	64.9	85.87	47.73	91.47	93.14
EBITDA Margin	5.60%	7.40%	11.06%	6.69%	13.08%	15.08%
D&A For EBITDA	10.35	10.07	11.31	11.56	9.08	6.31
EBIT	41.3	54.83	74.56	36.17	82.39	86.83
EBIT Margin	4.48%	6.25%	9.60%	5.07%	11.78%	14.06%
Effective Tax Rate	40.51%	31.94%	24.35%	43.70%	9.53%	9.07%
Advertising Expenses	-	0.03	0.01	0.27	0.22	0.07

Source: S&P Global Market Intelligence. Standard template. Financial Sources.